Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 21, 2023
Patent Application Number
16395839
Date Filed
April 26, 2019
Patent Citations
Patent Primary Examiner
The invention provides nucleic acids and nucleic acid expression vectors containing optimized mGluR6 promoters for expression of transgenes in the retina. The compositions and methods of the invention are useful for expression of gene products to preserve, improve, or restore phototransduction or vision.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
